Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.
作者信息
Shankar Lalitha K, Hoffman John M, Bacharach Steve, Graham Michael M, Karp Joel, Lammertsma Adriaan A, Larson Steven, Mankoff David A, Siegel Barry A, Van den Abbeele Annick, Yap Jeffrey, Sullivan Daniel
机构信息
Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
出版信息
J Nucl Med. 2006 Jun;47(6):1059-66.
PMID:16741317
Abstract
摘要
Zotero 插件